Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses

Overview of attention for article published in AIDS Research and Therapy, September 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#23 of 574)
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

blogs: 2 blogs
twitter: 2 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 87 Mendeley

Summary Blogs X Wikipedia Dimensions citations

So far, Dimensions has found 21 publications that cite this research output.

21

The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies

Article in Pharmaceutics (May 2023)

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV

Article in Vaccines (May 2023)

Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial

Article in Vaccine (March 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.